PMID- 28559271
OWN - NLM
STAT- MEDLINE
DCOM- 20180406
LR  - 20181113
IS  - 1098-6596 (Electronic)
IS  - 0066-4804 (Linking)
VI  - 61
IP  - 8
DP  - 2017 Aug
TI  - Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae 
      among Adult Patients in U.S. Hospitals.
LID - e00228-17 [pii]
LID - 10.1128/AAC.00228-17 [doi]
AB  - This large-scale retrospective analysis (n = 60,551) of the Premier inpatient
      database (1 January 2011 to 31 December 2014) found an overall prevalence of
      carbapenem-resistant Enterobacteriaceae strains of 2.3% (range, 0.9% to 5.8% by
      geographic region) among patients with infections due to Enterobacteriaceae
      Ongoing monitoring and development of decision support tools/algorithms are
      needed for identification of high-risk patients.
CI  - Copyright (c) 2017 American Society for Microbiology.
FAU - Lodise, Thomas
AU  - Lodise T
AD  - Albany College of Pharmacy and Health Sciences, Albany, New York, USA
      thomas.lodise@acphs.edu.
FAU - Ye, Michael J
AU  - Ye MJ
AD  - Allergan plc, Jersey City, New Jersey, USA.
FAU - Zhao, Qi
AU  - Zhao Q
AD  - Allergan plc, Jersey City, New Jersey, USA.
LA  - eng
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20170725
PL  - United States
TA  - Antimicrob Agents Chemother
JT  - Antimicrobial agents and chemotherapy
JID - 0315061
RN  - 0 (Anti-Bacterial Agents)
RN  - 0 (Carbapenems)
RN  - EC 3.5.2.6 (beta-Lactamases)
SB  - IM
MH  - Adult
MH  - Anti-Bacterial Agents/*pharmacology
MH  - Carbapenem-Resistant Enterobacteriaceae/drug effects/*isolation & purification
MH  - Carbapenems/*pharmacology/therapeutic use
MH  - Cross Infection
MH  - Enterobacteriaceae Infections/drug therapy/*epidemiology/microbiology
MH  - Hospitals
MH  - Humans
MH  - Microbial Sensitivity Tests
MH  - Prevalence
MH  - Retrospective Studies
MH  - United States/epidemiology
MH  - beta-Lactamases/genetics
PMC - PMC5527580
OTO - NOTNLM
OT  - *anti-infective agents
OT  - *bacteremia
OT  - *bacterial drug resistance
OT  - *bacterial infections
OT  - *bacterial pneumonia
OT  - *carbapenems
OT  - *intra-abdominal infections
OT  - *urinary tract infections
EDAT- 2017/06/01 06:00
MHDA- 2018/04/07 06:00
CRDT- 2017/06/01 06:00
PHST- 2017/02/01 00:00 [received]
PHST- 2017/05/24 00:00 [accepted]
PHST- 2017/06/01 06:00 [pubmed]
PHST- 2018/04/07 06:00 [medline]
PHST- 2017/06/01 06:00 [entrez]
AID - AAC.00228-17 [pii]
AID - 10.1128/AAC.00228-17 [doi]
PST - epublish
SO  - Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: AAC.00228-17. doi:
      10.1128/AAC.00228-17. Print 2017 Aug.